ÂÜÀòÂÒÂ×

Dr. Veronica Hall is the Chief Operating Officer at Clarametyx Biosciences, Inc. Veronica has over 20 years of experience in the biotechnology industry, with a focus on external development and pipeline program management.

Prior to joining Clarametyx, Dr. Hall was the Senior Director of External Development at Emergent BioSolutions, where they oversaw pipeline program development for all 4 business units: Vaccines and Anti-Infectives, Antibody Therapeutics, Devices, and Commercial Manufacturing. In this role, they were responsible for securing yearly R&D revenue of over $75M and building project budgets of up to $100M. Veronica also led and developed a team of 9 diverse, advanced degree individuals to a collaborative, cohesive, high-performing business unit.

During their time at Emergent BioSolutions, Dr. Hall launched and secured the company’s position in a new field by securing $23M in R&D from a revenue partner for a high-risk project in a critical therapeutic space. Veronica also grew the enterprise-wide opportunity pipeline, resulting in a 25% increase year-over-year in qualified opportunities and over $75M in annual R&D partnership revenue. In addition, they diversified the R&D pipeline by identifying 8 vaccines, therapeutics, or drug/device combination products. Dr. Hall also secured the largest award of $1.6B from a strategic alliance that advanced the company’s first cradle to grave vaccine to Phase 3 clinical studies. Lastly, they expanded the medical device portfolio and secured $63M in revenue by creating strategic alliances.

Dr. Hall received their PhD in Biochemistry from the University of California, Berkeley.

Veronica Hall, PhD, is a biochemist and cellular biologist who earned their undergraduate degree at the University of California, Santa Cruz in biochemistry and molecular biology. Veronica then went on to earn their PhD at Rice University in biochemistry and cellular biology.

They are on a team with Charles McOsker, PhD - Chief Scientific Officer, James Rogers, PhD - Director, Program Operations. Veronica Hall, PhD reports to David V. Richards, Chief Executive Officer.